Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Alzheimer's Disease

Trial Information

Safety and Tolerability of Etanercept in Alzheimer's Disease

Official Title: A Phase 2, Double-blind, Placebo-controlled Study of the Safety and Tolerability of Etanercept in Patients With Alzheimer's Disease

Summary

The primary aim of the study is to determine the safety and tolerability of etanercept in subjects with Alzheimer's Disease. The effects of etanercept on cognitive, behavioural, functional and immunological outcomes will be examined as secondary aims.

Phase: Phase 2

Sponsor: University of Southampton

Overall Contacts:

Joe W Butchart, MA MRCP
+44 (0)2380 475206

Locations (1)

Country State City Zip Facility and Contact
United Kingdom Hampshire Southampton SO30 3JB Memory Assessment and Research Centre, Moorgreen Hospital
Joe W Butchart, MA MRCP
+44 (0)2380 475206
jwb1m08@soton.ac.uk

Clive Holmes, PhD MRCPsych
Principal Investigator

Joe W Butchart, MA MRCP
Sub-Investigator

NCT ID:NCT01068353

Date Last Changed: January 10, 2011